| Financial Year |
March 31 2023 |
| Monetary Funds |
3,468,023,640.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
889,015,052.59 |
| Advances to Suppliers |
275,305,707.59 |
| Other Receivables |
2,831,817.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,269,044,538.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
565,671,682.70 |
| Total Current Assets |
8,493,312,404.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,959,127.54 |
| Investment Properties |
-- |
| Fixed Assetes |
2,570,271,533.74 |
| Under-construction Projects |
824,098,624.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
389,135,385.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,081,809.01 |
| Deferred Income Tax Assets |
17,892,899.82 |
| Other Non-Current Assets |
65,117,326.68 |
| Sub-Total of Non-Current Assets |
3,914,071,648.98 |
| Total Assets |
12,407,384,053.64 |
| Short-Term Loans |
4,063,818,265.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
355,639,614.20 |
| Accounts Payable |
586,431,328.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,158,945.82 |
| Taxes Payable |
52,047,808.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,388,476.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,162,984.42 |
| Other Current Liabilities |
54,672,790.53 |
| Sub-Total of Current Liabilities |
5,886,050,931.12 |
| Long-term Loans |
210,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,065,060.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
905,236,933.80 |
| Total Liabilities |
6,791,287,864.92 |
| Paid-In Capital(Or Share Stock) |
343,395,400.00 |
| Capital Surplus |
3,707,914,942.64 |
| Surplus Reserve |
60,832,623.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,503,953,223.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,616,096,188.72 |
| Owner's Equity（Stockholder's Equity） |
5,616,096,188.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,407,384,053.64 |
